Institutional Ownership C4 Therapeutics, Inc. (CCCC)
This table provides information about the institutional ownership of C4 Therapeutics, Inc. (CCCC). We have compiled data on the 130 institutions that hold shares in the stock, with a total of 63.5 Million shares, which have been reported (via 13F filing form) to have a value of $274 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Lynx1 Capital Management LP
San Juan, PR |
Nov 14, 2024 Q3 2024 |
6,880,527
shares
|
$29.7 Million
14.04% of portfolio
|
Q3 2024
New holding
|
|
Soleus Capital Management, L.P.
Greenwich, CT |
Nov 14, 2024 Q3 2024 |
6,603,996
shares
|
$28.5 Million
3.2% of portfolio
|
Q3 2024
Added 62.98%
|
|
Wasatch Advisors Inc
Salt Lake City, UT |
Nov 14, 2024 Q3 2024 |
5,677,368
shares
|
$24.5 Million
0.16% of portfolio
|
Q3 2024
Added 17.13%
|
|
Ra Capital Management, L.P.
Boston, MA |
Nov 14, 2024 Q3 2024 |
4,878,000
shares
|
$21 Million
0.39% of portfolio
|
Q2 2024
New holding
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,551,510
shares
|
$19.6 Million
0.0% of portfolio
|
Q2 2024
Added 402.93%
|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
4,377,900
shares
|
$18.9 Million
0.59% of portfolio
|
Q3 2024
Added 189.34%
|
|
Commodore Capital LP
New York, NY |
Nov 14, 2024 Q3 2024 |
3,410,384
shares
|
$14.7 Million
1.65% of portfolio
|
Q1 2024
Reduced 10.25%
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
3,370,681
shares
|
$14.5 Million
0.0% of portfolio
|
Q3 2024
Reduced 5.23%
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
2,806,913
shares
|
$12.1 Million
0.0% of portfolio
|
Q3 2024
Reduced 6.28%
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
2,326,134
shares
|
$10 Million
0.0% of portfolio
|
Q3 2024
Added 104.42%
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
2,036,233
shares
|
$8.78 Million
0.0% of portfolio
|
Q3 2024
Added 15.14%
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
1,369,676
shares
|
$5.9 Million
0.0% of portfolio
|
Q3 2024
Added 0.55%
|
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
Nov 14, 2024 Q3 2024 |
1,319,484
shares
|
$5.69 Million
0.11% of portfolio
|
Q3 2024
Added 6.04%
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Nov 14, 2024 Q3 2024 |
1,201,848
shares
|
$5.18 Million
0.02% of portfolio
|
Q3 2024
Added 331.42%
|
|
Silverarc Capital Management, LLC
|
Nov 14, 2024 Q3 2024 |
1,147,891
shares
|
$4.95 Million
1.63% of portfolio
|
Q3 2024
Reduced 20.44%
|
|
Bain Capital Life Sciences Investors, LLC
Boston, MA |
Nov 14, 2024 Q3 2024 |
1,111,910
shares
|
$4.79 Million
1.14% of portfolio
|
Q2 2024
Reduced 2.65%
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Nov 14, 2024 Q3 2024 |
1,065,500
shares
|
$4.59 Million
0.01% of portfolio
|
Q3 2024
Reduced 23.45%
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
828,490
shares
|
$3.57 Million
0.01% of portfolio
|
Q3 2024
Reduced 36.65%
|
|
Tang Capital Management LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
700,000
shares
|
$3.02 Million
0.34% of portfolio
|
Q3 2024
Added 250.0%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 07, 2024 Q3 2024 |
578,885
shares
|
$2.49 Million
0.0% of portfolio
|
Q3 2024
Reduced 6.5%
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Nov 14, 2024 Q3 2024 |
520,000
shares
|
$2.24 Million
0.01% of portfolio
|
Q3 2024
New holding
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
505,852
shares
|
$2.18 Million
0.0% of portfolio
|
Q3 2024
Reduced 31.44%
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
489,820
shares
|
$2.11 Million
0.0% of portfolio
|
Q3 2024
Added 172.77%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
482,929
shares
|
$2.08 Million
0.0% of portfolio
|
Q3 2024
Reduced 1.23%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
392,004
shares
|
$1.69 Million
0.0% of portfolio
|
Q3 2024
Added 529.15%
|